JP Morgan Chase’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.05M Buy
647,518
+221,560
+52% +$1.98M ﹤0.01% 3140
2025
Q4
$3.6M Sell
425,958
-36,421
-8% -$260K ﹤0.01% 3609
2025
Q3
$2.41M Sell
462,379
-3,876,024
-89% -$14.8M ﹤0.01% 3940
2025
Q2
$15M Sell
4,338,403
-571,368
-12% -$1.7M ﹤0.01% 2179
2025
Q1
$12.9M Sell
4,909,771
-68,672
-1% -$269K ﹤0.01% 2323
2024
Q4
$20.5M Sell
4,978,443
-539,073
-10% -$2.93M ﹤0.01% 2026
2024
Q3
$39.1M Buy
5,517,516
+1,554,115
+39% +$11.6M ﹤0.01% 1489
2024
Q2
$25.8M Buy
3,963,401
+246,133
+7% +$1.68M ﹤0.01% 1670
2024
Q1
$30.9M Sell
3,717,268
-2,348,327
-39% -$22.9M ﹤0.01% 1588
2023
Q4
$66.8M Buy
6,065,595
+929,111
+18% +$7.84M 0.01% 1077
2023
Q3
$43.2M Buy
5,136,484
+141,579
+3% +$1.52M 0.01% 1183
2023
Q2
$62.7M Buy
4,994,905
+694,079
+16% +$8.63M 0.01% 1018
2023
Q1
$70.8M Sell
4,300,826
-169,072
-4% -$3.03M 0.01% 941
2022
Q4
$66.8M Sell
4,469,898
-548,589
-11% -$10.5M 0.01% 958
2022
Q3
$112M Buy
5,018,487
+76,225
+2% +$1.67M 0.02% 678
2022
Q2
$82.8M Buy
4,942,262
+1,667,873
+51% +$35.7M 0.01% 819
2022
Q1
$98M Sell
3,274,389
-92,923
-3% -$2.25M 0.01% 849
2021
Q4
$103M Buy
3,367,312
+1,940,330
+136% +$61.3M 0.01% 869
2021
Q3
$45M Buy
1,426,982
+3,655
+0.3% +$123K 0.01% 1233
2021
Q2
$52.1M Buy
1,423,327
+43,821
+3% +$1.44M 0.01% 1205
2021
Q1
$47.7M Buy
1,379,506
+88,977
+7% +$3.86M 0.01% 1182
2020
Q4
$53.6M Buy
1,290,529
+76,091
+6% +$3.44M 0.01% 1034
2020
Q3
$48.6M Buy
+1,214,438
New +$46.3M 0.01% 988

Other funds holding RLAY